Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
11
self-reported 11–50 band
Founded
2007
19 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Description
NiSCELL is a Malaysian Biotechnology Company incorporated in 2007 to principally engage in laboratory research on cell based products and developing immunotherapy for cancer and stem cell therapy for regenerative diseases. NiSCELL’s technology originated from Japan. Besides being a Bionexus Status company, NiSCELL in 2009 was accredited with GMP (Good Manufacturing Practice) status certified by National Pharmaceutical Regulatory Agency (NPRA) and blood bank licensed by the Ministry of Health Malaysia.
NiSCELL provides a platform for collaborators where there is a potential for cell-based therapy for regenerative disorders.
NiSCELL core strength is to manufacture human peripheral blood derived Natural Killer (NK) Cells, Cytotoxic T Lymphocytes (CTL) and Umbilical Cord-derived allogenic Mesenchymal Stem Cells (MSCs) in order to facilitate their effective use in basic and translational research as well as for future clinical applications.
Our live cell-based products are manufactured in our own cGMP compliant facility and handled by high profile scientists. These products are being pre-clinically investigated for frailty and various cancer treatments.
Our core strength is possession of technology and materials, all patented for isolation, processing, expansion and preservation of clinically usable stem cells, progenitor cells, precursor cells as well as mature cells. We are committed to the highest international standards for ethics and scientific values.
NiSCELL will focus on providing facilities to Hospitals and Doctors to Regenerate health with Immunotherapy and Stem Cells.
Specialties
All 1 specialty
- Stem Cells and Immunotherapy
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | MY |
All codes: MY
Addresses
- MYPetaling JayaPrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at NiSCELL?
11 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does NiSCELL have offices?
One address on record, Malaysia only. Primary: Petaling Jaya.
Has NiSCELL raised funding?
None linked to this brand.
What does NiSCELL list as its specialties?
One tag on the brand's own list, among them Stem Cells and Immunotherapy.
Which companies are listed alongside NiSCELL?
Nine peer profiles on record: Cell Tissue Technology Sdn Bhd and CytoHealth®.